This protocol applies to paediatric patients younger than 16 years presenting with juvenile absence epilepsy. Patient age is a primary factor shaping how treatment is selected and sequenced in this condition.
The regimen for this age group involves antiepileptic drug therapy, and the protocol defines specific criteria for when and how combination therapy becomes appropriate. The complete treatment algorithm — including agent selection, sequencing, and escalation thresholds — is available in the full protocol.